ARNAArena Pharmaceuticals Inc


$ 99.99 $ 0.06 (0.06 %)    

Thursday, 10-Mar-2022 15:59:59 EST
QQQ $ 451.64 $ -0.92 (-0.2 %)
DIA $ 399.14 $ -0.07 (-0.02 %)
SPY $ 528.49 $ -1.09 (-0.21 %)
TLT $ 92.06 $ -0.09 (-0.1 %)
GLD $ 220.06 $ -0.86 (-0.39 %)
$ 99.99
$ 99.97 x 1,000
$ 100.01 x 1,000
-- - --
$ 45.50 - $ 100.00
5,718,504
na
na
$ 0.77
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 bullish-tuesday-for-marijuana-stocks---nine-energy-service-renesola-among-top-gainers

GAINERS: Nine Energy Service (NYSE:NINE) shares closed up 57.66% at $5.66

 pfizers-cannabinoid-related-biotech-company-arenas-q4-net-loss-grows-27-yoy

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) revealed Wednesday financial results for the fourth quarter and full year ended Dec....

 arena-pharmaceuticals-q4-eps-254-misses-226-estimate-sales-5400k-miss-66000k-estimate

Arena Pharmaceuticals (NASDAQ:ARNA) reported quarterly losses of $(2.54) per share which missed the analyst consensus estimate ...

 arena-pharmaceuticals-q4-earnings-insights

Arena Pharmaceuticals (NASDAQ:ARNA) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM. Here's w...

 the-daily-biotech-pulse-kodiak-sinks-on-adverse-study-outcome-marinus-flags-delay-in-clinical-trial-mainz-biomed-gains-on-positive-regulatory-development

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kodiak's Wet AMD Tr...

 earnings-scheduled-for-february-23-2022

  Companies Reporting Before The Bell • Sapiens Intl Corp (NASDAQ:SPNS) is likely to report earnings for its fourth quarter.

 the-week-ahead-in-biotech-feb-20-26-reata-awaits-fda-decision-bausch-health-moderna-lead-earnings-news-flow

Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tension...

 expert-ratings-for-arena-pharmaceuticals

Arena Pharmaceuticals (NASDAQ:ARNA) has observed the following analyst ratings within the last quarter:

 hc-wainwright--co-downgrades-arena-pharmaceuticals-to-neutral-lowers-price-target-to-100

HC Wainwright & Co. analyst Patrick Trucchio downgrades Arena Pharmaceuticals (NASDAQ:ARNA) from Buy to Neutral and lowe...

 10-biggest-price-target-changes-for-tuesday

B of A Securities lifted the price target on Micron Technology, Inc. (NASDAQ: MU) from $76 to $100. Micron shares rose 7.7%...

 cantor-fitzgerald-downgrades-arena-pharmaceuticals-to-neutral-raises-price-target-to-100

Cantor Fitzgerald analyst Alethia Young downgrades Arena Pharmaceuticals (NASDAQ:ARNA) from Overweight to Neutral and raises...

 benzingas-bulls-and-bears-of-the-past-week-pfizer-bank-of-america-beyond-meat-gamestop-amc-overstock-and-more

Benzinga has examined the prospects for many investor favorite stocks over the past week.

 the-week-in-cannabis-pfizer-visa-730m-in-financings-malta-eu-columbia-care-medmen-uruguay-and-more

Below is a recap of the main news related to the cannabis industry and markets for the week of December 13, 2021. Contents

 what-6-analyst-ratings-have-to-say-about-arena-pharmaceuticals

Over the past 3 months, 6 analysts have published their opinion on Arena Pharmaceuticals (NASDAQ:ARNA) stock. These analysts ar...

 citigroup-downgrades-arena-pharmaceuticals-to-neutral-lowers-price-target-to-100

Citigroup analyst Neena Bitritto-Garg downgrades Arena Pharmaceuticals (NASDAQ:ARNA) from Buy to Neutral and lowers the pric...

 10-biggest-price-target-changes-for-tuesday

B of A Securities lifted the price target on Apple Inc. (NASDAQ: AAPL) from $160 to $210. Apple shares rose 0.4% to $176.37...

 jmp-securities-downgrades-arena-pharmaceuticals-to-market-perform

JMP Securities analyst Jason Butler downgrades Arena Pharmaceuticals (NASDAQ:ARNA) from Market Outperform to Market Perform.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION